Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Dow
Mallinckrodt
Citi
Johnson and Johnson
Colorcon
Queensland Health
Accenture
Chubb

Generated: February 16, 2019

DrugPatentWatch Database Preview

Litigation Details for Bayer AG v. Dr. Reddy's Lab.Ltd. (D. Del. 2004)

« Back to Dashboard

Bayer AG v. Dr. Reddy's Lab.Ltd. (D. Del. 2004)

Docket ➤ Try a Free Trial Date Filed 2004-03-24
Court District Court, D. Delaware Date Terminated 2007-11-28
Cause 28:1338 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties BAYER AG; BAYER HEALTHCARE AG; BAYER PHARMACEUTICALS CORPORATION; DR. REDDY'S LABORATORIES, INC.; DR. REDDY'S LABORATORIES, LTD.
Patents 4,602,017; 4,670,444; 4,980,470; 4,990,517; 5,001,161; 5,229,382; 5,607,942
Attorneys David Ellis Moore; Frederick L. Cottrell , III; Kathleen Furey McDonough; Louis H. Weinstein; Maurice Ross; Richard L. Horwitz; Rudolf E. Hutz
Link to Docket External link to docket

Details for Bayer AG v. Dr. Reddy's Lab.Ltd. (D. Del. 2004)

Date Filed Document No. Description Snippet Link To Document
2006-03-03 108 Exhibit 7 BLANK DTX120 US Patent No. 4,670,444 (D120) 6/2/87 Relevance… DRLMOX 033497 – Certified Patent, U.S. Patent No. 3/4/97 033549 … Patent Office cover page (P65) DTX187 DRLMOX 041560 – US Patent No. 4,990,517…DTX244 DLRMOX030842 – Certified Patent, European Patent 1/25/89 Relevance …DTX245 DRLMOX030836 – 30838 Certified Patent, Japanese Patent 10/12/84 Relevance, Hearsay External link to document
2006-10-06 132 (Part 2) claims l, 2, 8, 9 and ll of United States Patent 4,990,517 patent invalid for obviousness under 35 U"… 5 of United States Patent 4,990,517. 4r FIND United States Patent 4,990,51'7 unenforceable for inequitable…any of claims l(}, l2, or 14 ofUnited States Patent 4,990,517 when manufactured, sold, imported, exported…conduct that renders each of United States Patents 4,990,517 and 5,607,94.?. unenforceable Respectfully…later patent is invalid over an earlier patent if: a) the subject matter claimed in the later patent was External link to document
2006-10-06 133 Exhibit A filed a patent infringement suit to protect its rights under U.S. Patent 4,602,017 (the “‘017 patent”) which…of double patenting, “same invention” double patenting and “obviousness-type” double patenting. Same invention…nonstatutory double patenting compares claims in an earlier patent to claims in a later patent or application…than one patent on the same invention if the subject matter is identical to an earlier patent. _§e 35 …variations from the earlier patent. §d. To prevent the issuance of a patent on claims that are nearly identical External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fuji
Colorcon
UBS
Medtronic
Merck
Baxter
Julphar
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.